Validation of a New Quantitative Blood Test, Nash-Fibrotest-2 (NT-2), for Assessing Nash Severity in a Phase 2 Clinical Trial of Selonsertib-MedSci.cn

Validation of a New Quantitative Blood Test, Nash-Fibrotest-2 (NT-2), for Assessing Nash Severity in a Phase 2 Clinical Trial of Selonsertib

Peta, V; Jayakumar, S; Mantry, PS; Lawitz, EJ; Djedjos, S; Subramanian, M; Myers, RP; Diehl, AM; Caldwell, S; Charlton, MR; Afdhal, NH; Goodman, ZD; Poynard, T; Loomba, R

HEPATOLOGY, 2018; 68 (): 1299A

科室
- - 订阅+
  - 更多科室
工具
服务